Literature DB >> 32883876

Anacardic acid, interleukin-33, and the quest for remyelination.

Murali Ramanathan1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32883876      PMCID： PMC7502744          DOI： 10.1073/pnas.2015884117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.

Authors:  Yuriy Pomeshchik; Iurii Kidin; Paula Korhonen; Ekaterina Savchenko; Merja Jaronen; Sarka Lehtonen; Sara Wojciechowski; Katja Kanninen; Jari Koistinaho; Tarja Malm
Journal:  Brain Behav Immun       Date:  2014-08-18       Impact factor: 7.217

2.  CNS injury: IL-33 sounds the alarm.

Authors:  Simmie L Foster; Sébastien Talbot; Clifford J Woolf
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

3.  Olesoxime accelerates myelination and promotes repair in models of demyelination.

Authors:  Karine Magalon; Celine Zimmer; Myriam Cayre; Joseph Khaldi; Clarisse Bourbon; Isabelle Robles; Gwenaëlle Tardif; Angèle Viola; Rebecca M Pruss; Thierry Bordet; Pascale Durbec
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

Review 4.  Macrophages and CNS remyelination.

Authors:  Veronique E Miron; Robin J M Franklin
Journal:  J Neurochem       Date:  2014-03-26       Impact factor: 5.372

Review 5.  Emerging roles of anacardic acid and its derivatives: a pharmacological overview.

Authors:  Mahadevappa Hemshekhar; Martin Sebastin Santhosh; Kempaiah Kemparaju; Kesturu S Girish
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-12-22       Impact factor: 4.080

6.  A regenerative approach to the treatment of multiple sclerosis.

Authors:  Brian R Lawson; Peter G Schultz; Luke L Lairson; Vishal A Deshmukh; Virginie Tardif; Costas A Lyssiotis; Chelsea C Green; Bilal Kerman; Hyung Joon Kim; Krishnan Padmanabhan; Jonathan G Swoboda; Insha Ahmad; Toru Kondo; Fred H Gage; Argyrios N Theofilopoulos
Journal:  Nature       Date:  2013-10-09       Impact factor: 49.962

7.  Anacardic acid induces IL-33 and promotes remyelination in CNS.

Authors:  Åsa Ljunggren-Rose; Chandramohan Natarajan; Pranathi Matta; Akansha Pandey; Isha Upender; Subramaniam Sriram
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-17       Impact factor: 11.205

8.  IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages.

Authors:  Hui-Rong Jiang; Marija Milovanović; Debbie Allan; Wanda Niedbala; Anne-Galle Besnard; Sandra Y Fukada; Jose C Alves-Filho; Dieudonnée Togbe; Carl S Goodyear; Christopher Linington; Damo Xu; Miodrag L Lukic; Foo Y Liew
Journal:  Eur J Immunol       Date:  2012-06-12       Impact factor: 5.532

Review 9.  Potential biological applications of bio-based anacardic acids and their derivatives.

Authors:  Fatma B Hamad; Egid B Mubofu
Journal:  Int J Mol Sci       Date:  2015-04-16       Impact factor: 5.923

10.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.

Authors:  Robin J M Franklin; Charles Ffrench-Constant; Veronique E Miron; Amanda Boyd; Jing-Wei Zhao; Tracy J Yuen; Julia M Ruckh; Jennifer L Shadrach; Peter van Wijngaarden; Amy J Wagers; Anna Williams
Journal:  Nat Neurosci       Date:  2013-07-21       Impact factor: 24.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.